July 3, 2009
Home - Latest Headlines
Information
Most Viewed
- The Bioidentical Hormone Debate:
Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious than Commonly Used Synthetic Versions in Hormone Replacement Therapy? - Nonalcoholic Fatty Liver Disease:
Hepatic Manifestation of Obesity and the Metabolic Syndrome - A Quick Guide to Evidence-Based Chronic Kidney Disease Care for the Primary Care Physician
Weekly Poll
A Special Report
Featured Articles
Answers to the Most Common Questions About the Hepatic Safety Profile of Duloxetine
Madelaine M. Wohlreich, MD; Nayan Acharya, MD; Indiana Strombom, PhD; Louis Kuritzky, MD; Michael Robinson, MD; Alexandra N. Heinloth, MD; Arie Regev, MD; and Joachim F. Wernicke, MD, PhD
Madelaine M. Wohlreich, MD; Nayan Acharya, MD; Indiana Strombom, PhD; Louis Kuritzky, MD; Michael Robinson, MD; Alexandra N. Heinloth, MD; Arie Regev, MD; and Joachim F. Wernicke, MD, PhD
Solifenacin at 3 Years: A Review of Efficacy and Safety
Richard S. Pelman, MD; James P. Capo, Jr., MD; and Sergio Forero-Schwanhaeuser, MD
Richard S. Pelman, MD; James P. Capo, Jr., MD; and Sergio Forero-Schwanhaeuser, MD
Original Research:
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief as an Adjunctive Therapy to Antibiotic Treatment of Acute Respiratory Infections
Craig LaForce, MD; Deborah A. Gentile, MD; and David P. Skoner, MD
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief as an Adjunctive Therapy to Antibiotic Treatment of Acute Respiratory Infections
Craig LaForce, MD; Deborah A. Gentile, MD; and David P. Skoner, MD
Free Access Articles
Strategies for Implementing and Sustaining Therapeutic Lifestyle Changes as Part of Hypertension Management in African Americans
Margaret Scisney-Matlock, PhD, RN,FAAN; Hayden B. Bosworth, PhD; Joyce Newman Giger, EdD, RN, ARPN, BC, FAAN; Ora L. Strickland, PhD, DSc(Hon), RN, FAAN; R. Van Harrison, PhD; Dorothy Coverson, PhD, RN; Nirav R. Shah, MD, MPH; Cheryl R. Dennison, ANP, PhD; Jacqueline M. Dunbar-Jacob, PhD, RN, FAAN; Loretta Jones, MA; Gbenga Ogedegbe, MD, MPH, MS; Marian L. Batts-Turner, MSN, RN, CDE; and Kenneth A. Jamerson, MD
Margaret Scisney-Matlock, PhD, RN,FAAN; Hayden B. Bosworth, PhD; Joyce Newman Giger, EdD, RN, ARPN, BC, FAAN; Ora L. Strickland, PhD, DSc(Hon), RN, FAAN; R. Van Harrison, PhD; Dorothy Coverson, PhD, RN; Nirav R. Shah, MD, MPH; Cheryl R. Dennison, ANP, PhD; Jacqueline M. Dunbar-Jacob, PhD, RN, FAAN; Loretta Jones, MA; Gbenga Ogedegbe, MD, MPH, MS; Marian L. Batts-Turner, MSN, RN, CDE; and Kenneth A. Jamerson, MD
Original Research:
Intravenous Ribavirin-Review of the FDA's Emergency Investigational New Drug Database (1997-2008) and Literature Review
Andrea Riner, MPH; Kirk M. Chan-Tack, MD; and Jeffrey S. Murray, MD, MPH
Intravenous Ribavirin-Review of the FDA's Emergency Investigational New Drug Database (1997-2008) and Literature Review
Andrea Riner, MPH; Kirk M. Chan-Tack, MD; and Jeffrey S. Murray, MD, MPH
Renin-Angiotensin-Aldosterone System Blockade in Diabetes:
Role of Direct Renin Inhibitors
Raymond O. Estacio, MD
Role of Direct Renin Inhibitors
Raymond O. Estacio, MD
Insights from the Liraglutide Clinical Development Program–the Liraglutide Effect and Action in Diabetes (LEAD) Studies
Janet B. McGill, MD
Janet B. McGill, MD
Adding Liraglutide to Oral Antidiabetic Drug Monotherapy:
Efficacy and Weight Benefits
Michael Nauck, MD, PhD and Michael Marre, MD, PhD
Efficacy and Weight Benefits
Michael Nauck, MD, PhD and Michael Marre, MD, PhD
Maternal Obesity and Pregnancy
Hemant K. Satpathy, MD; Alfred Fleming, MD; Donald Frey, MD; Michael Barsoom, MD; Chabi Satpathy, MD; and Katie Fossen, MD
Hemant K. Satpathy, MD; Alfred Fleming, MD; Donald Frey, MD; Michael Barsoom, MD; Chabi Satpathy, MD; and Katie Fossen, MD
Bariatric Surgery:
Is it Right for Your Patient?
Eve S. Guth, MD and Edward H. Livingston, MD, FACS, AGAF
Is it Right for Your Patient?
Eve S. Guth, MD and Edward H. Livingston, MD, FACS, AGAF
Obesity and Coronary Artery Disease Risk in Native Americans
David Alexander Leaf, MD, MPH and Ifeoma Stella Izuchukwu, MD, MPH
David Alexander Leaf, MD, MPH and Ifeoma Stella Izuchukwu, MD, MPH
Nonalcoholic Fatty Liver Disease:
Hepatic Manifestation of Obesity and the Metabolic Syndrome
Hima Boppidi, MD and Sumanth R. Daram, MD, FACP
Hepatic Manifestation of Obesity and the Metabolic Syndrome
Hima Boppidi, MD and Sumanth R. Daram, MD, FACP
Clinical Manifestations of Food Allergy:
Differentiating True Allergy From Food Intolerance
Nathaniel D. Hare, MD and Mary Beth Fasano, MD, MSPH
Differentiating True Allergy From Food Intolerance
Nathaniel D. Hare, MD and Mary Beth Fasano, MD, MSPH
A Quick Guide to Evidence-Based Chronic Kidney Disease Care for the Primary Care Physician
Chester H. Fox, MD; Vasu Voleti, MBBS; Linda S. Khan, PhD; Brian Murray, MD; and Joseph Vassalotti, MD
Chester H. Fox, MD; Vasu Voleti, MBBS; Linda S. Khan, PhD; Brian Murray, MD; and Joseph Vassalotti, MD
Internal Hernia After Laparoscopic Gastric Bypass Surgery:
A Case Report and Literature Review
Heidi Morgan, DO; Robert Chastanet, MD; and Paul A. Lucha, Jr., DO
A Case Report and Literature Review
Heidi Morgan, DO; Robert Chastanet, MD; and Paul A. Lucha, Jr., DO
The Effects of Pharmacologic Agents for Type 2 Diabetes Mellitus on Body Weight
F. Xavier Pi-Sunyer, MD
F. Xavier Pi-Sunyer, MD
Flashback Articles
Plastic or Somatopsychic Surgery
Zvi Neuman, M.D.
Date: Postgraduate Medicine Vol.33 No.2, April 1963
Zvi Neuman, M.D.
Date: Postgraduate Medicine Vol.33 No.2, April 1963
Indications for Abdominal Exploration When Cancer Is Suspected
Waltman Walters, M.D.
Date: Postgraduate Medicine Vol.33 No.2, April 1963
Waltman Walters, M.D.
Date: Postgraduate Medicine Vol.33 No.2, April 1963